Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GTP in Advanced Transitional Cell Carcinoma of the Urothelium
NCT00310011Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jun 1998
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, paclitaxel, cisplatin in transitional cell carcinoma of the urothelium (TCC), sponsored by Wake Forest University Health Sciences. Started Jun 1998; status: completed.
02
Drugs
gemcitabinepaclitaxelcisplatin
03
Conditions
transitional cell carcinoma of the urothelium (TCC)
Beyond the preview
Go deeper on NCT00310011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00310011.